我们的中间体产品组合
我们生产多种高品质医药中间体，这些中间体是API合成不可或缺的组成部分。
| 产品名称 | 中间体名称 | CAS编号 |
|---|---|---|
| Abrocitinib | (1s,3s)-N1-methyl-N1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)cyclobutane-1,3-diamine hydrogen chloride | |
| Abrocitinib | benzyl ((1s,3s)-3-([2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)cyclobutyl)carbamate | |
| Adagrasib | 1-Bromo-8-chloronaphthalene | 20816-79-9 |
| Adagrasib | 1-(Tetrahydropyran-2-yl)-1H-pyrazole-5-boronic acid pinacol ester | 903550-26-5 |
| Alogliptin Benzoate | 6-Chloro-3-methyluracil | 4318-56-3 |
| Alogliptin Benzoate | 2-[(6−Chloro−3,4−dihydro−3−methyl−2,4−dioxo−1(2H)−pyrimidinyl)methyl]benzonitrile | 865758-96-9 |
| Alogliptin Benzoate | 2-(4-Fluorophenyl)thiophene | 58861-48-6 |
| Alogliptin Benzoate | 2,3,4,6-Tetra-O-pivaloyl-alpha-D-glucopyranosyl bromide | 81058-27-7 |
| ATOGEPANT | L-Phenylalanine, N-acetyl-, compd. with (3S,5S,6R)-3-amino-6-methyl-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)-2-piperidinone (1:1) | 1456803-45-4 |
| ATOGEPANT | (S)-2'-Oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic acid | 1375541-21-1 |
| ATOGEPANT | Tert-butyl ((3S,5S,6R)-6-methyl-2-oxo-5-(2,3,6-trifluorophenyl)piperidin-3-yl)carbamate | 1456803-43-2 |
| ATOGEPANT | 2H-Pyrrolo[2,3-b]pyridin-2-one, 3-[[5-chloro-3-[[(tetrahydro-2H-pyran-2-yl)oxy]methyl]-2-pyridinyl]methylene]-1-(1,1-dimethylethyl)-1,3-dihydro-, (3Z) | 1456804-07-1 |
| ATOGEPANT | Tert-butyl ((5S,6R)-6-methyl-2-oxo-5-(2,3,6-trifluorophenyl)piperidin-3-yl)carbamate | 1456803-42-1 |
| AGOMELATINE | 7-Methoxy-1-Tetralone | 6836-19-7 |
| AGOMELATINE | (7-methoxy-1-naphthyl)acetonitrile | 138113-08-3 |
| APIXABAN | 1-(4-aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridinone | 1267610-26-3 |
| APIXABAN | 3-morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one | 545445-44-1 |
| APIXABAN | Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate | 27143-07-3 |
| APIXABAN | 1-(4-Iodo-Phenyl)-Piperidin-2-One | 385425-15-0 |
| APIXABAN | 1-(4-Bromo-Phenyl)-Piperidin-2-One | 27471-43-8 |
| APIXABAN | 1-( 4-Nitro-Phenyl)-Piperidin-2-One | 38560-30-4 |
| APIXABAN | 3-Chloro-5,6-dihydro-1-(4-nitrophenyl)-2(1H)-pyridinone | 536760-29-9 |
| APIXABAN | 5,6-Dihydro-3-(4-morpholinyl)-1-(4-nitrophenyl)-2(1H)-pyridinone | 503615-03-0 |
| APIXABAN | 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-Pyrazolo[3,4-c]pyridine-3-carboxylic acid,ethyl ester | 536759-91-8 |
| APIXABAN | 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phH-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester | 503614-91-3 |
| APREMILAST | 3-Ethoxy-4-methoxy-alpha-[(methylsulfonyl)methyl]-benzenemethanamine | 253168-94-4 |
| APREMILAST | 3-Acetylaminophthalic anhydride | 6296-53-3 |
| APREMILAST | N-Acetyl-L-leucine | 1188-21-2 |
| APREMILAST | (S)-2-(3-Ethoxy-4-methoxyphenyl)-1-methyl sulphonyl)-eth-2yl amine | 608141-42-0 |
| APREMILAST | 3-Ethoxy-4-methoxybenzaldehyde | 1131-52-8 |
| APREPITANT | (R)-1-[3,5-Bis(trilfuoromethyl)phenyl]ethanol | 127852-28-2 |
| APREPITANT | (S)-1-[3,5-Bis(trilfuoromethyl)phenyl]ethanol | 225920-05-8 |
| APREPITANT | N-Methylcarbonyl-2-chloroacetamidrazone | 155742-64-6 |
| APREPITANT | 3-Chloromethyl-1,2,4-triazolin-5-one | 252742-72-6 |
| Azilsartan medoxomil potassium | Methyl 1-2 −cyanobiphenyl−4−yl)methyl]−2−ethoxy−1H−benzimidazole−7−carboxylate | 139481-44-0 |
| Azilsartan medoxomil potassium | 1H-Benzimidazole-7-carboxylic acid, 1-[[2 −[(2,5−dihydro−5−oxo−1,2,4−oxadiazol−3−yl)][1,1 −biphenyl]−4−yl]Methyl]−2−ethoxy−,Methyl ester | 147403-52-9 |
| Azilsartan medoxomil potassium | 4-(HydroxyMethyl)-5-Methyl-[1,3]dioxol-2-one | 91526-18-0 |
| Azilsartan medoxomil potassium | Azilsartan base | 147403-03-0 |
| Bexagliflozin | 4-bromo-1-chloro-2-(4-(2-cyclopropoxyethoxy)benzyl)benzene | 1118567-45-5 |
| Bexagliflozin | (3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahydro-2H-pyran-2-one | 32384-65-9 |
| CANAGLIFLOZIN | 2,3,4,6-Tetra-O-pivaloyl-alpha-D-glucopyranosyl bromide | 81508-27-7 |
| CANAGLIFLOZIN | 2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene | 898566-17-1 |
| CANAGLIFLOZIN | 2,3,4,6-Tetrakis -O-Trimethylsilyl-D-Gluconolactone | 32384-65-9 |
| CAPECITABINE | 2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine | 161599-46-8 |
| CAPECITABINE | 5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-diacetate | 162204-20-8 |
| CINACALCET | R)-1-(naphthalen-1-yl)ethanamine | 3886-70-2 |
| CINACALCET | 3-(3-trifluoromethylphenyl)propionaldehyde | 21172-41-8 |
| CINACALCET | 3-(3-(trifluoromethyl)phenyl)propan-1-ol | 78573-45-2 |
| CINACALCET | 3-(Trifluoromethyl)cinnamic acid | 779-89-5 |
| CINACALCET | (R)-(+)-alpha-(1-Naphthyl)ethylamine | 3886-70-2 |
| CINACALCET | (R)-(+)-alpha-(1-Naphthyl)ethylamine hydrochloride | 82572-04-1 |
| CINACALCET | 3-(3-(trifluoromethyl)phenyl)propanoic acid | 585-50-2 |
| Crizinotib | [5-Bromo-3-[(1R)−(2,6−dichloro−3−fluorophenyl)ethoxy]pyridin−2−yl]amine | 877399-00-3 |
| Crizinotib | tert-butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylate | 877399-74-1 |
| Crizinotib | 4-[4-[6-Amino-5-[[(R)−1−(2,6−dichloro−3−fluorophenyl)ethyl]oxy]pyridin−3−yl]pyrazol−1−yl]piperidine−1−carboxylicacidtert−butylester | 877399-51-4 |
| DABIGATRAN ETEXILATE | Ethyl N-[3-amino-4-(methylamino) benzoyl]-N-pyridin-2-yl-beta-alaninate | 212322-56-0 |
| DABIGATRAN ETEXILATE | N-(4-Cyano-Phenyl)-Glycine | 42288-26-6 |
| DABIGATRAN ETEXILATE | N-[[2-[[(4-cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester | 211915-84-3 |
| DABIGATRAN ETEXILATE | Alanine,N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-,ethyl ester,monohydrochloride | 211914-50-0 |
| DABIGATRAN ETEXILATE | Ethyl 3-(pyridin-2-ylamino)propanoate | 103041-38-9 |
| DABIGATRAN ETEXILATE | Ethyl 3-(4-(methylamino)-3-nitro-N-(pyridin-2-yl)benzamido)propanoate | 429659-01-8 |
| DABIGATRAN ETEXILATE | N-[2-[4-[N-(Hexyloxycarbonyl)amidino]phenylaminomethyl]-1-methyl-1H-benzimidazol-5-ylcarbonyl]-N-(2-pyridyl)-beta-alanine ethyl ester | 211915-06-9 |
| DAPAGLIFLOZIN | 5-Bromo-2-chlorobenzoic acid | 21739-92-4 |
| DAPAGLIFLOZIN | (5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone | 461432-22-4 |
| DAPAGLIFLOZIN | [(2R,3R,4R,5S,6S)-3,4,5-triacetyloxy-6-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]oxan-2-yl]methyl acetate | 461432-25-7 |
| DAPAGLIFLOZIN | (3R,4S,5R,6R)-3,4,5-tris(trimethylsilyloxy)-6-(trimethylsilyloxymethy l)oxan-2-one | 32384-65-9 |
| DAPAGLIFLOZIN | 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene | 1103738-29-9 |
| DAPAGLIFLOZIN | 2-Chloro-5-iodobenzoic Acid | 19094-56-5 |
| DAPAGLIFLOZIN | 5-Bromo-2-Chloro-4-Ethoxydiphenylmethane | 461432-23-5 |
| DAPAGLIFLOZIN | methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]--D-Glucopyranoside | 714269-57-5 |
| Darolutamide | 1-Bromo-8-chloronaphthalene | 20816-79-9 |
| Darolutamide | 1-(Tetrahydropyran-2-yl)-1H-pyrazole-5-boronic acid pinacol ester | |
| Darolutamide | 5-Acetylpyrazole-3-carboxylic Acid | |
| DARUNAVIR | 2S,3S)-1,2-epoxy-3-(Boc-amino)-4-Phenylnutane | 98737-29-2 |
| DARUNAVIR | (3aS,4S.6aR)-Tetrahydro-4-Methoxyfuro[3,4-b]furan-2(3H)-one | 866594-60-7 |
| DARUNAVIR | [(3R,3aS,6aR)-Hydroxyhexahydrofuro[2,3-أں]furanyl Succinimidyl Carbonate | 253265-97-3 |
| DARUNAVIR | (3aS,6aR)-Tetrahydro-4-methoxyfuro[3,4-b]furan-2(3H)-one | 501921-30-8 |
| DARUNAVIR | (2S,3S)-3-amino-1-chloro-4-phenylbutan-2-ol hydrochloride | 166987-16-2 |
| DARUNAVIR | (3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-ol | 156928-09-5 |
| DARUNAVIR | Benzenesulfonamide, 4-amino-N-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-(2-methylpropyl) | 169280-56-2 |
| DELAMANID | R)-2-Chloro-1-(2-methyl-2,3-epoxy-propyl)-4-nitroimidazole | 681490-93-7 |
| DELAMANID | (R)-2-chloro-1-[2-hydroxy-2-methyl-3-(4-nitrobenzoyloxy)]-propyl-4-nitroimidazole | 681490-95-9 |
| DELAMANID | 4-[4-(4-Trifluoromethoxyphenoxy)-piperidin-1-yl]-phenol | 681482-81-5 |
| DECRAVACITINIB | N,N-Dimethylformamide dimethyl acetal | 4637-24-5 |
| DECRAVACITINIB | 4,6-Dichloro-N-(methyl-d3)-3-pyridazinecarboxamide | 1609393-89-6 |
| DECRAVACITINIB | Cyclopropanecarboxamide | 6228-73-5 |
| DECRAVACITINIB | Tripotassium phosphate | 7778-53-2 |
| DECRAVACITINIB | N-Acetylcysteine | 616-91-1 |
| DECRAVACITINIB | (2R)-1-[(1R)-1-[Bis(1,1-dimethylethyl)phosphino]ethyl]-2-(diphenylphosphino)ferrocene(Josiphos SL-J009) | 1702311-34-9 |
| DECRAVACITINIB | (2S)-1-[(1S)-1-[Bis(1,1-dimethylethyl)phosphino]ethyl]-2-(diphenylphosphino)ferrocene | 277306-29-3 |
| DECRAVACITINIB | 3-(2-Methoxy-3-nitrophenyl)-1-methyl-1H-1,2,4-triazole | 1609394-08-2 |
| DECRAVACITINIB | Propylphosphonic anhydride | 68957-94-8 |
| DECRAVACITINIB | Methyl-d3-amine hydrochloride | 7436-22-8 |
| DECRAVACITINIB | Diazabicyclo (5.4.0) undec-7-ene | 23411-34-9 |
| DECRAVACITINIB | 2-Methoxy-3-nitrobenzamide | 722538-98-9 |
| DECRAVACITINIB | 2-Methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)benzenamine | 1609394-10-6 |
| DOLUTEGRAVIR | 1-(2,2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid | 1335210-23-5 |
| DOLUTEGRAVIR | (4R,12aS)-7-(benzyloxy)-N-(2,4-difluorobenzyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | 1206102-11-5 |
| DOLUTEGRAVIR | Dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate | 1246616-66-9 |
| DOLUTEGRAVIR | Methyl-5-(2,4-difluorobenzylcarbamoyl)-1-(2,2-dimethoxyethyl)-3-methoxy-4-oxo-1,4-dihydropyridine-2-carboxylate | 1616340-68-1 |
| DOLUTEGRAVIR | 4R,12aS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide | 1335210-35-9 |
| DOLUTEGRAVIR | 2,4-Difluorobenzylamine | 72235-52-0 |
| DOLUTEGRAVIR | R-3-aminobutanol | 61477-40-5 |
| DORZOLAMIDE | 2-Mercaptothiophene | 7774-74-5 |
| DORZOLAMIDE | (3S)-3-(2-Thienylthio)butanoic acid compd. with (alphaR)-alpha-methylbenzenemethanamine | 1197375-23-7 |
| DORZOLAMIDE | (3S)-3-(2-thienylthio)butanoic acid | 133359-80-5 |
| DORZOLAMIDE | (6S)-5,6-Dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-one | 147086-79-1 |
| DORZOLAMIDE | (6S)-6-methyl-4-oxo-5,6-Dihydro-4H-thio{(2,3-b)thiopyaran-2-sulphonamide | 1383784-43-7 |
| DORZOLAMIDE | 6-Methyl-4-oxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide | 120279-88-1 |
| DORZOLAMIDE | (6S)-5,6-Dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-one 7,7-dioxide | 148719-91-9 |
| DORZOLAMIDE | (4R,6S)-5,6-Dihydro-4-hydroxy-6-methylthieno[2,3-b]thiopyran-7,7-dioxide | 147128-77-6 |
| DORZOLAMIDE | (4S,6S)-5,6-Dihydro-4-hydroxy-6-methylthieno[2,3-b]thiopyran-7,7-dioxide | 147086-81-5 |
| DORZOLAMIDE | N-[(4S,6S)-6-Methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-yl]acetamide | 147086-83-7 |
| DORZOLAMIDE | N-[(4S,6S)-6-Methyl-7,7-dioxo-2-sulfamoyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-yl]acetamide | 147200-03-1 |